Want to join the conversation?
$SNDK 2Q15 Call: 2Q15 results benefited from more favorable performance than expected in enterprise and retail. Enterprise SSDs, Fusion-io revenue grew sequentially in 2Q15 and announced the next generation Fusion ioMemoryTM PCIe application accelerators.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?